Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott B Phillips, MD
Elorac, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope
Duarte, California, United States
- Stanford University
Palo Alto, California, United States
- Ussf Health Morsani Center for Advanced Healthcare
Tampa, Florida, United States
- Cleveland Clinic Indian River Hospital
Vero Beach, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Dawes Fretzin Clinical Research Group, Llc
Indianapolis, Indiana, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- St. Louis University Dermatology
St Louis, Missouri, United States
- Washington University School of Medicine St. Louis
St Louis, Missouri, United States
- Stony Brook Dermatology
Stony Brook, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Inova Schar Cancer Institute
Fairfax, Virginia, United States
- University of Washington / Seattle Cancer Care Alliance (scca)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2017
- Primary completion
- 30 Sept 2022
- Completion
- 30 Sept 2022
- Last update posted
- 28 Oct 2022
- Registered enrollment
- 59
- Registry id
- NCT02811783
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.